Paroxysmal atrial fibrillation: changes in factor VIII and von Willebrand factor impose early hypercoagulability M Negreva, K Prodanova, K Vitlianova, C Madjova Archives of Medical Science - Atherosclerotic Diseases 1 (5), 140-147, 2020 | 11 | 2020 |
Early effects of paroxysmal atrial fibrillation on plasma markers of fibrinolysis M Negreva, S Georgiev, K Vitlianova Medicine 95 (45), e5184, 2016 | 11 | 2016 |
Early changes in the antithrombin and thrombin-antithrombin complex in patients with paroxysmal atrial fibrillation M Negreva, S Georgiev, K Prodanova, J Nikolova Cardiology Research 7 (3), 89, 2016 | 11 | 2016 |
Effect of selective beta-blockade with bisoprolol in the treatment of recent-onset atrial fibrillation MN Negreva, AP Penev Folia Med (Plovdiv) 54 (2), 27-31, 2012 | 10 | 2012 |
Assessment of copper status in patients with paroxysmal atrial fibrillation MN Negreva, SJ Georgiev, AP Penev, RB Georgieva, AA Alexandrova J. Cardiobiol 2 (2), 1-5, 2014 | 9 | 2014 |
Paroxysmal Atrial Fibrillation: Insight Into the Intimate Mechanisms of Coagulation M Negreva, A Zarkova, K Prodanova, P Petrov Cardiology Research 11 (1), 22-32, 2020 | 7 | 2020 |
Significant increase in C-reactive protein and serum amyloid A in the early hours of paroxysmal atrial fibrillation M Negreva, S Georgiev, K Prodanova Cardiology Research 7 (1), 1, 2016 | 6 | 2016 |
Cytokine Interleukine-6 in Patients with Paroxysmal Atrial Fibrillation AD Negreva M, Georgiev S, Prodanova K, Vitlianova K International Journal of Pharmaceutical and Medical Research 3 (4), 16-20, 2015 | 5 | 2015 |
Paroxysmal atrial fibrillation: dynamics of the main antioxidant enzymes-superoxide dismutase and catalase MN Negreva, AP Penev, SZ Georgiev, AA Aleksandrova Folia Medica 56 (2), 96, 2014 | 5 | 2014 |
Decreased activity of the protein C anticoagulant pathway in the early hours of paroxysmal atrial fibrillation M Negreva, S Georgiev, K Vitlianova Clinical and Applied Thrombosis/Hemostasis 23 (7), 793-799, 2017 | 4 | 2017 |
Paroxysmal Atrial Fibrillation: An Independent Risk Factor for Prothrombotic Conditions M Negreva, K Prodanova, A Zarkova Journal of atrial fibrillation 13 (2), 1-6, 2020 | 3 | 2020 |
Nonlinear dynamics methods for analysis of ECG signals E Gospodinova, M Gospodinov, M Negreva Proceedings of the 21st International Conference on Computer Systems and …, 2020 | 3 | 2020 |
Interleukin-4 and paroxysmal atrialfibrillation M Negreva, S Georgiev, K Prodanova,, K Vitlianova, D Arabadzhieva Merit research journal of medicine and medical sciences 3, 271-277, 2015 | 3 | 2015 |
Dynamics of oxidative status in patients with paroxysmal atrial fibrillation M Negreva, S Georgiev, A Penev, A Alexandrova Scripta Scientifica Medica 46 (3), 33-41, 2014 | 3 | 2014 |
Paroxysmal atrial fibrillation is associated with early coagulation activity regardless of risk factors for embolism MN Negreva, KS Prodanova, KD Vitlianova Minerva. Cardiol. Angiol 69, 269-276, 2021 | 2 | 2021 |
Diagnostic Values of Some Fibrinolytic Indicators for Rejecting the Presence of Paroxysmal Atrial Fibrillation K Prodanova, M Negreva, K Vitlianova International Journal of Basic Sciences and Applied Computing 2 (12), 1-6, 2020 | 2 | 2020 |
073_16773-H1 early markers of coagulation activity prothrombin fragments 1+ 2 and fibrinopeptide A are significantly increased in patients with paroxysmal atrial fibrillation M Negreva, K Vitlianov, R Tasheva JACC: Clinical Electrophysiology 3 (10S), S23-S23, 2017 | 2 | 2017 |
Selenium status in paroxysmal atrial fibrillation M Negreva, S Georgiev, K Vitlianova, R Georgieva Int J Med Pharm 3, 17-26, 2015 | 2 | 2015 |
Changes in glucose-6-phosphate dehydrogenase activity in paroxysmal atrial fibrillation MN Negreva, AP Penev, SJ Georgiev, AA Alexandrova J Cardiobiol 2 (1), 5, 2014 | 2 | 2014 |
Status of Selenium and Selenoprotein Gluthation Peroxidase in Patients with recent-onset Atrial Fibrillation M Negreva, A Penev, S Georgiev, A Aleksandrova, R Georgieva Journal of Atrial Fibrillation, 2013 | 2 | 2013 |